-
Je něco špatně v tomto záznamu ?
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia
G. Fazio, V. Massa, A. Grioni, V. Bystry, S. Rigamonti, C. Saitta, M. Galbiati, C. Rizzari, C. Consarino, A. Biondi, A. Selicorni, G. Cazzaniga,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu kazuistiky, časopisecké články
NLK
ProQuest Central
od 2000-01-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2000-01-01 do Před 6 měsíci
- MeSH
- de Langeové syndrom diagnóza genetika MeSH
- dědičnost MeSH
- fenotyp MeSH
- genetická predispozice k nemoci MeSH
- lidé MeSH
- mutace * MeSH
- mutační analýza DNA MeSH
- pre-B-buněčná leukemie diagnóza genetika terapie MeSH
- předškolní dítě MeSH
- proteiny genetika MeSH
- recidiva MeSH
- rodokmen MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
Cornelia de Lange syndrome (CdLS) is a rare autosomal-dominant genetic disorder characterised by prenatal and postnatal growth and mental retardation, facial dysmorphism and upper limb abnormalities. Germline mutations of cohesin complex genes SMC1A, SMC3, RAD21 or their regulators NIPBL and HDAC8 have been identified in CdLS as well as somatic mutations in myeloid disorders. We describe the first case of a paediatric patient with CdLS with B-cell precursor Acute Lymphoblastic Leukaemia (ALL). The patient did not show any unusual cytogenetic abnormality, and he was enrolled into the high risk arm of AIEOP-BFM ALL2009 protocol because of slow early response, but 3 years after discontinuation, he experienced an ALL relapse. We identified a heterozygous mutation in exon 46 of NIPBL, causing frameshift and a premature stop codon (RNA-Targeted Next generation Sequencing Analysis). The analysis of the family indicated a de novo origin of this previously not reported deleterious variant. As for somatic cohesin mutations in acute myeloid leukaemia, also this ALL case was not affected by aneuploidy, thus suggesting a major impact of the non-canonical role of NIPBL in gene regulation. A potential biological role of NIPBL in leukaemia has still to be dissected.
Central European Institute of Technology Masarykova Univerzita Brno Czech Republic
Centro di Ricerca Tettamanti Clinica Pediatrica Università di Milano Bicocca Monza Italy
Department of Pediatrics Presidio S Fermo ASST Lariana Como Italy
Dipartimento di Scienze della Salute Università degli Studi di Milano Milano Italy
Ematologia ed Oncologia Pediatrica Presidio Ospedaliero Ciaccio De Lellis Catanzaro Italy
Pediatric Department Monza Brianza per il Bambino e la sua Mamma Foundation Monza Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034659
- 003
- CZ-PrNML
- 005
- 20191014102833.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/jclinpath-2019-205707 $2 doi
- 035 __
- $a (PubMed)30948435
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Fazio, Grazia $u Centro di Ricerca Tettamanti, Clinica Pediatrica, Università di Milano, Bicocca, Monza, Italy.
- 245 10
- $a First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia / $c G. Fazio, V. Massa, A. Grioni, V. Bystry, S. Rigamonti, C. Saitta, M. Galbiati, C. Rizzari, C. Consarino, A. Biondi, A. Selicorni, G. Cazzaniga,
- 520 9_
- $a Cornelia de Lange syndrome (CdLS) is a rare autosomal-dominant genetic disorder characterised by prenatal and postnatal growth and mental retardation, facial dysmorphism and upper limb abnormalities. Germline mutations of cohesin complex genes SMC1A, SMC3, RAD21 or their regulators NIPBL and HDAC8 have been identified in CdLS as well as somatic mutations in myeloid disorders. We describe the first case of a paediatric patient with CdLS with B-cell precursor Acute Lymphoblastic Leukaemia (ALL). The patient did not show any unusual cytogenetic abnormality, and he was enrolled into the high risk arm of AIEOP-BFM ALL2009 protocol because of slow early response, but 3 years after discontinuation, he experienced an ALL relapse. We identified a heterozygous mutation in exon 46 of NIPBL, causing frameshift and a premature stop codon (RNA-Targeted Next generation Sequencing Analysis). The analysis of the family indicated a de novo origin of this previously not reported deleterious variant. As for somatic cohesin mutations in acute myeloid leukaemia, also this ALL case was not affected by aneuploidy, thus suggesting a major impact of the non-canonical role of NIPBL in gene regulation. A potential biological role of NIPBL in leukaemia has still to be dissected.
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a de Langeové syndrom $x diagnóza $x genetika $7 D003635
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a dědičnost $7 D040941
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a pre-B-buněčná leukemie $x diagnóza $x genetika $x terapie $7 D015452
- 650 _2
- $a proteiny $x genetika $7 D011506
- 650 _2
- $a recidiva $7 D012008
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Massa, Valentina $u Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy.
- 700 1_
- $a Grioni, Andrea $u Centro di Ricerca Tettamanti, Clinica Pediatrica, Università di Milano, Bicocca, Monza, Italy. Central European Institute of Technology, Masarykova Univerzita, Brno, Czech Republic.
- 700 1_
- $a Bystry, Vojtech $u Central European Institute of Technology, Masarykova Univerzita, Brno, Czech Republic.
- 700 1_
- $a Rigamonti, Silvia $u Centro di Ricerca Tettamanti, Clinica Pediatrica, Università di Milano, Bicocca, Monza, Italy. Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy.
- 700 1_
- $a Saitta, Claudia $u Centro di Ricerca Tettamanti, Clinica Pediatrica, Università di Milano, Bicocca, Monza, Italy.
- 700 1_
- $a Galbiati, Marta $u Centro di Ricerca Tettamanti, Clinica Pediatrica, Università di Milano, Bicocca, Monza, Italy.
- 700 1_
- $a Rizzari, Carmelo $u Pediatric Department, Monza Brianza per il Bambino e la sua Mamma (MBBM) Foundation, Monza, Italy.
- 700 1_
- $a Consarino, Caterina $u Ematologia ed Oncologia Pediatrica, Presidio Ospedaliero Ciaccio-De Lellis, Catanzaro, Italy.
- 700 1_
- $a Biondi, Andrea $u Centro di Ricerca Tettamanti, Clinica Pediatrica, Università di Milano, Bicocca, Monza, Italy. Pediatric Department, Monza Brianza per il Bambino e la sua Mamma (MBBM) Foundation, Monza, Italy.
- 700 1_
- $a Selicorni, Angelo $u Department of Pediatrics, Presidio S. Fermo, ASST Lariana, Como, Italy gianni.cazzaniga@hsgerardo.org angelo.selicorni61@gmail.com.
- 700 1_
- $a Cazzaniga, Giovanni $u Centro di Ricerca Tettamanti, Clinica Pediatrica, Università di Milano, Bicocca, Monza, Italy gianni.cazzaniga@hsgerardo.org angelo.selicorni61@gmail.com. Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza, Italy.
- 773 0_
- $w MED00002597 $t Journal of clinical pathology $x 1472-4146 $g Roč. 72, č. 8 (2019), s. 558-561
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30948435 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191014103257 $b ABA008
- 999 __
- $a ok $b bmc $g 1451319 $s 1073209
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 72 $c 8 $d 558-561 $e 20190404 $i 1472-4146 $m Journal of clinical pathology $n J Clin Pathol $x MED00002597
- LZP __
- $a Pubmed-20191007